blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3855184

EP3855184 - METHODS FOR TREATING AND MONITORING THE STATUS OF CANCER [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  24.11.2023
Database last updated on 08.10.2024
FormerGrant of patent is intended
Status updated on  17.07.2023
FormerExamination is in progress
Status updated on  04.11.2022
FormerRequest for examination was made
Status updated on  21.01.2022
FormerThe application has been published
Status updated on  25.06.2021
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): PL, PT, SK		published on 04.09.2024  [2024/36]
Applicant(s)For all designated states
Stemline Therapeutics Inc.
750 Lexington Avenue, 11th Floor
New York, NY 10022 / US
[2021/30]
Inventor(s)01 / CIRRITO, Thomas P.
475 48th Avenue
Apt. 3703
Long Island City New York, NY 11109 / US
02 / BERGSTEIN, Ivan
c/o Stemline Therapeutics, Inc.
750 Lexington Avenue, 11th Floor
New York, NY 10022 / US
03 / BROOKS, Christopher
271 18th Street, N° 2
Brooklyn New York, NY 11215-5406 / US
 [2021/30]
Representative(s)Graham Watt & Co LLP
St. Botolph's House
7-9 St. Botolph's Road
Sevenoaks TN13 3AJ / GB
[2021/30]
Application number, filing date20211725.519.03.2013
[2021/30]
Priority number, dateUS201261612826P19.03.2012         Original published format: US 201261612826 P
[2021/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3855184
Date:28.07.2021
Language:EN
[2021/30]
Type: B1 Patent specification 
No.:EP3855184
Date:27.12.2023
Language:EN
[2023/52]
Search report(s)(Supplementary) European search report - dispatched on:EP18.05.2021
ClassificationIPC:G01N33/574
[2021/30]
CPC:
G01N33/57407 (EP,US); C07K16/40 (US); A61K38/1793 (EP,US);
A61K38/45 (EP,US); A61P25/00 (EP); A61P35/00 (EP);
A61P37/04 (EP); C07K16/2866 (US); C12N9/12 (EP,US);
A61K2039/505 (US); C12Y207/10001 (EP,US); G01N2333/70596 (US);
G01N2333/7155 (US); G01N2333/91205 (US); G01N2800/52 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/08]
Former [2021/30]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERFAHREN ZUR BEHANDLUNG UND ÜBERWACHUNG EINES KARZINOMSTATUS[2021/30]
English:METHODS FOR TREATING AND MONITORING THE STATUS OF CANCER[2021/30]
French:PROCÉDÉS DE TRAITEMENT ET DE SURVEILLANCE DE L'ÉTAT D'UN CANCER[2021/30]
Examination procedure19.01.2022Amendment by applicant (claims and/or description)
19.01.2022Examination requested  [2022/08]
19.01.2022Date on which the examining division has become responsible
04.11.2022Despatch of a communication from the examining division (Time limit: M04)
06.03.2023Reply to a communication from the examining division
18.07.2023Communication of intention to grant the patent
16.11.2023Receipt of the translation of the claim(s)
17.11.2023Fee for grant paid
17.11.2023Fee for publishing/printing paid
Parent application(s)   TooltipEP13763504.1  / EP2828664
EP18189485.8  / EP3431997
Divisional application(s)EP23210443.0  / EP4361634
Fees paidRenewal fee
31.03.2021Renewal fee patent year 03
31.03.2021Renewal fee patent year 04
31.03.2021Renewal fee patent year 05
31.03.2021Renewal fee patent year 06
31.03.2021Renewal fee patent year 07
31.03.2021Renewal fee patent year 08
12.03.2021Renewal fee patent year 09
18.02.2022Renewal fee patent year 10
14.02.2023Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.12.2023
CZ27.12.2023
EE27.12.2023
FI27.12.2023
HR27.12.2023
LT27.12.2023
LV27.12.2023
NL27.12.2023
PL27.12.2023
RO27.12.2023
RS27.12.2023
SE27.12.2023
SK27.12.2023
SM27.12.2023
BG27.03.2024
NO27.03.2024
IS27.04.2024
PT29.04.2024
[2024/36]
Former [2024/35]AT27.12.2023
CZ27.12.2023
EE27.12.2023
FI27.12.2023
HR27.12.2023
LT27.12.2023
LV27.12.2023
NL27.12.2023
RO27.12.2023
RS27.12.2023
SE27.12.2023
SM27.12.2023
BG27.03.2024
NO27.03.2024
IS27.04.2024
Former [2024/34]EE27.12.2023
FI27.12.2023
HR27.12.2023
LT27.12.2023
LV27.12.2023
NL27.12.2023
RS27.12.2023
SE27.12.2023
SM27.12.2023
BG27.03.2024
NO27.03.2024
IS27.04.2024
Former [2024/33]FI27.12.2023
HR27.12.2023
LT27.12.2023
LV27.12.2023
NL27.12.2023
RS27.12.2023
SE27.12.2023
SM27.12.2023
BG27.03.2024
NO27.03.2024
IS27.04.2024
Former [2024/32]FI27.12.2023
HR27.12.2023
LT27.12.2023
LV27.12.2023
NL27.12.2023
RS27.12.2023
SE27.12.2023
BG27.03.2024
NO27.03.2024
IS27.04.2024
Former [2024/26]FI27.12.2023
HR27.12.2023
LT27.12.2023
LV27.12.2023
NL27.12.2023
RS27.12.2023
SE27.12.2023
BG27.03.2024
NO27.03.2024
Former [2024/21]FI27.12.2023
LT27.12.2023
BG27.03.2024
Documents cited:Search[A]US2008175870  (MATHER JENNIE P [US], et al);
 [A]US2011229504  (FRITSCHE JENS [DE], et al);
 [A]US2012052080  (OKADA HIDEHO [US]);
by applicantGB2220211
 US5057540
 WO9300686
 US5441050
 US6162432
 US2002168360
 WO02098370
 US2005002934
 WO2007109812
 WO2007109813
 WO2007US64857
 WO2007US64858
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.